These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8822632)

  • 1. The syn3 strain HSZP of herpes simplex virus type 1 (HSV-1) is not pathogenic for mice and shows limited neural spread.
    Rajcáni J; Vojvodová A; Matis J; Kúdelová M; Dragúnová J; Krivjanská M; Zelník V
    Virus Res; 1996 Jul; 43(1):33-44. PubMed ID: 8822632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of glycoprotein B gene in the herpes simplex virus type 1 strain ANGpath DNA by that originating from nonpathogenic strain KOS reduces the pathogenicity of recombinant virus.
    Kostál M; Bacík I; Rajcáni J; Kaerner HC
    Acta Virol; 1994 Apr; 38(2):77-88. PubMed ID: 7976866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus 1 (HSV-1) strain HSZP glycoprotein B gene: comparison of mutations among strains differing in virulence.
    Kosovský J; Vojvodová A; Oravcová I; Kúdelová M; Matis J; Rajcáni J
    Virus Genes; 2000; 20(1):27-33. PubMed ID: 10766304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the DNA target sequence of poorly reactivable strain HSZP of herpes simplex virus type 1 by polymerase chain reaction.
    Kúdelová M; Dragún M; Kosovský J; Matis J; Rajcáni J
    Acta Virol; 1996 Feb; 40(1):15-21. PubMed ID: 8886093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of strain HSZP of herpes simplex virus type 1 (HSV1).
    Rajcáni J; Kúdelová M; Oravcová I; Vojvodová A; Kosovský J; Matis J
    Folia Microbiol (Praha); 1999; 44(6):713-9. PubMed ID: 11097032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of glycoprotein C of HSZP strain of herpes simplex virus 1.
    Oravcová I; Kúdelová M; Mlcuchová J; Matis J; Bystrická M; Westra DF; Welling-Wester S; Rajcáni J
    Acta Virol; 2000 Apr; 44(2):99-108. PubMed ID: 10989701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regions US6 and US7 of herpes simplex virus type 1 DNA encoding glycoproteins D and I may influence neuroinvasivity.
    Rajcáni J; Kostál M; Kaerner HC
    Acta Virol; 1994 Apr; 38(2):89-95. PubMed ID: 7976867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syn strains HSZP and ANGpath [correction of ANG] of herpes simplex virus type 1 do not contain mutations in the regions of UL53 gene relevant to syncytium formation.
    Kúdelová M; Vojvodová A; Rajcáni J
    Acta Virol; 1998 Feb; 42(1):41-5. PubMed ID: 9645242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus type 1 (HSV-1) strain HSZP host shutoff gene: nucleotide sequence and comparison with HSV-1 strains differing in early shutoff of host protein synthesis.
    Vojvodová A; Matis J; Kúdelová M; Rajcáni J
    Virus Genes; 1997; 15(2):155-9. PubMed ID: 9421879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of the low-pH inactivated herpes simplex virus type 1 (HSV-1) strain HSZP with the early shutoff function of superinfecting HSV-1 strain KOS.
    Matis J; Kúdelová M; Rajcáni J
    Virus Res; 1999 Mar; 60(1):81-6. PubMed ID: 10225276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthesis of the major DNA-binding protein (ICP8) in cells infected with the strain HSZP or KOS of herpes simplex virus type 1.
    Matis J; Krivjanská M
    Acta Virol; 1991 Jan; 35(1):44-53. PubMed ID: 1683115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single amino acid substitutions in the glycoprotein B carboxy terminus influence the fusion from without property of herpes simplex virus type 1.
    Lingen M; Seck T; Weise K; Falke D
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1843-9. PubMed ID: 9049391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel single amino acid syncytial mutations in the carboxy terminus of glycoprotein B of herpes simplex virus type 1 confer a unique pathogenic phenotype.
    Engel JP; Boyer EP; Goodman JL
    Virology; 1993 Jan; 192(1):112-20. PubMed ID: 8390747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific binding of herpes simplex virus type 1 (HSV-1) strain HSZP to host cell surface can provoke interference with early shutoff of host protein synthesis induced by HSV-1 strain KOS.
    Matis J; Krivjanská M
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():2053-8. PubMed ID: 8046408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spread of herpes simplex virus (HSV) strains SC16, ANG, ANGpath and its glyC minus and GlyE minus mutants in DBA-2 mice.
    Rajcáni J; Herget U; Kaerner HC
    Acta Virol; 1990 Aug; 34(4):305-20. PubMed ID: 1981441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus type 1 (HSV-1) HSZP interferes also heat inactivated with early shutoff of host protein synthesis induced by HSV-1 KOS.
    Matis J; Krivjanská M
    Acta Virol; 1988 Sep; 32(5):379-85. PubMed ID: 2904731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes Simplex Virus 1 Mutant with Point Mutations in
    Mostafa HH; Thompson TW; Konen AJ; Haenchen SD; Hilliard JG; Macdonald SJ; Morrison LA; Davido DJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
    Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic potentials of glycoprotein C-negative syncytial mutants from rabbit T cells infected persistently with herpes simplex virus type 1.
    Ishida Y; Okabe T; Azukizawa Y; Isono T; Seto A
    J Med Virol; 2005 May; 76(1):89-97. PubMed ID: 15779044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation.
    Rajcáni J; Sabó A; Mucha V; Kostál M; Compel P
    Acta Virol; 1995 Feb; 39(1):37-49. PubMed ID: 7572468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.